Lightning Round OT: Cerner, MannKind and More
MannKind : “It’s got some FDA hurdles up ahead,” Cramer said. So stay away from MNKD.
Exide Technologies : XIDE could work as a good speculation play, Cramer said.
Cerner : Cramer is bullish on CERN.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the Mad Money website? firstname.lastname@example.org